Biotech · Public company · Bridgewater, NJ, US
INSMED Inc
Ticker INSM · SEC CIK 0001104506
Track this companyFree. Adds INSMED Inc to your Dealase workspace and tells you when its record changes.
Clinical trials257 recruiting or active
Pipeline programs30From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline30
- ALISPhase 3 · Mycobacterium Infections, NontuberculousClinicalTrials.gov · fetched Nov 12, 2026
- AzithromycinPhase 3 · Mycobacterium Infections, NontuberculousClinicalTrials.gov · fetched Nov 12, 2026
- Brensocatib 10 mgPhase 3 · Non-Cystic Fibrosis BronchiectasisClinicalTrials.gov · fetched Nov 12, 2026
- Brensocatib 25 mgPhase 3 · Non-Cystic Fibrosis BronchiectasisClinicalTrials.gov · fetched Nov 12, 2026
- ELCPhase 3 · Mycobacterium Infections, NontuberculousClinicalTrials.gov · fetched Nov 12, 2026
- EthambutolPhase 3 · Mycobacterium Infections, NontuberculousClinicalTrials.gov · fetched Nov 12, 2026
- Treprostinil PalmitilPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Treprostinil Palmitil Inhalation PowderPhase 3 · Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Treprostinil Palmitil Inhalation PowderPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Treprostinil Palmitil Inhalation PowderPhase 3 · Progressive Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- BrensocatibPhase 2 · Hidradenitis SuppurativaClinicalTrials.gov · fetched Nov 12, 2026
- BrensocatibPhase 2 · Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- BrensocatibPhase 2 · Chronic Rhinosinusitis Without Nasal PolypsClinicalTrials.gov · fetched Nov 12, 2026
- Mometasone furoate nasal spray (MFNS)Phase 2 · Chronic Rhinosinusitis Without Nasal PolypsClinicalTrials.gov · fetched Nov 12, 2026
- OpSCFPhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- BrensocatibPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- BrensocatibPhase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- Brensocatib Oral SolutionPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- Brensocatib Oral TabletPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- C16TRPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- ClarithromycinPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- EsomeprazolePhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- INS1007Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- INS1033Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- RifampinPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- TPIP F2Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- TPIP F3Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Treprostinil Palmitil Inhalation PowderPhase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- Treprostinil Palmitil Inhalation PowderPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Tyvaso®Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary Fibrosis (PPF)PHASE3 · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07805785 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy ParticipantsPHASE1 · RECRUITING · started Aug 25, 2026ClinicalTrials.gov NCT07765706 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)PHASE3 · RECRUITING · started Jul 21, 2026ClinicalTrials.gov NCT07481981 · fetched Nov 12, 2026
- An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)PHASE3 · RECRUITING · started Jul 20, 2026ClinicalTrials.gov NCT07234032 · fetched Nov 12, 2026
- A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic ImpairmentPHASE1 · RECRUITING · started Jul 14, 2026ClinicalTrials.gov NCT07643155 · fetched Nov 12, 2026
- Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)PHASE3 · RECRUITING · started Jan 7, 2026ClinicalTrials.gov NCT07179380 · fetched Nov 12, 2026
- A Study to Assess the Relative Bioavailability After a Single Inhalation Administration of Treprostinil Palmitil Inhalation Powder (TPIP) Formulation 2 (F2) to TPIP Formulation 3 (F3) in Healthy ParticipantsPHASE1 · COMPLETED · started Aug 19, 2025ClinicalTrials.gov NCT07102316 · fetched Nov 12, 2026
- A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)PHASE2 · TERMINATED · started Dec 16, 2024ClinicalTrials.gov NCT06685835 · fetched Nov 12, 2026
- A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy ParticipantsPHASE1 · COMPLETED · started Apr 30, 2024ClinicalTrials.gov NCT06344728 · fetched Nov 12, 2026
- A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy ParticipantsPHASE1 · COMPLETED · started Dec 27, 2023ClinicalTrials.gov NCT06178783 · fetched Nov 12, 2026
- Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe AD (Atopic Dermatitis)PHASE2 · COMPLETED · started Nov 21, 2023ClinicalTrials.gov NCT06101823 · fetched Nov 12, 2026
- A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)PHASE2 · COMPLETED · started Oct 30, 2023ClinicalTrials.gov NCT06013241 · fetched Nov 12, 2026
- A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy ParticipantsPHASE1 · COMPLETED · started Jul 28, 2023ClinicalTrials.gov NCT05965570 · fetched Nov 12, 2026
- A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy ParticipantsPHASE1 · COMPLETED · started May 10, 2023ClinicalTrials.gov NCT05826574 · fetched Nov 12, 2026
- An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Mar 7, 2023ClinicalTrials.gov NCT05649748 · fetched Nov 12, 2026
- A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic ImpairmentPHASE1 · COMPLETED · started Oct 4, 2022ClinicalTrials.gov NCT05517525 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial HypertensionPHASE2 · COMPLETED · started Aug 24, 2022ClinicalTrials.gov NCT05147805 · fetched Nov 12, 2026
- A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)PHASE2 · TERMINATED · started Mar 29, 2022ClinicalTrials.gov NCT04791514 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic FibrosisPHASE2 · COMPLETED · started Nov 30, 2021ClinicalTrials.gov NCT05090904 · fetched Nov 12, 2026
- Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium ComplexPHASE3 · COMPLETED · started Apr 1, 2021ClinicalTrials.gov NCT04677569 · fetched Nov 12, 2026
- Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium ComplexPHASE3 · COMPLETED · started Dec 22, 2020ClinicalTrials.gov NCT04677543 · fetched Nov 12, 2026
- A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis BronchiectasisPHASE3 · COMPLETED · started Dec 1, 2020ClinicalTrials.gov NCT04594369 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy ParticipantsPHASE1 · COMPLETED · started Sep 17, 2020ClinicalTrials.gov NCT06091579 · fetched Nov 12, 2026
- A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian ParticipantsPHASE1 · COMPLETED · started Jan 9, 2019ClinicalTrials.gov NCT05927597 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy ParticipantsPHASE1 · COMPLETED · started Nov 17, 2015ClinicalTrials.gov NCT06193031 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 16, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 23, 2026 · fetched Nov 12, 2026